<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02099968</url>
  </required_header>
  <id_info>
    <org_study_id>CORONA</org_study_id>
    <nct_id>NCT02099968</nct_id>
  </id_info>
  <brief_title>Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial</brief_title>
  <official_title>Intensivierte Ern채hrungs- Und Lebensstilmodifikation Bei Patienten Mit Bluthochdruck Und Kardiometabolischer Risikokonstellation. Eine Zweizentrische Randomisiert-kontrollierte Interventionsstudie 체ber 6 Monate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universit채t Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kliniken Essen-Mitte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Immanuel Hospital Berlin, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Witten/Herdecke</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universit채t Duisburg-Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different forms of diet, e.g. Mediterranean diet, DASH diet, or fasting, have demonstrated
      efficacy in reducing elevated blood pressure. Moreover, Mediterranean diet, and fasting seem
      to be effective in improving insulin sensitivity in type 2 diabetes. Further, studies on
      meditation or mindfulness-based interventions have shown positive effects in patients with
      hypertension and/or type 2 diabetes. Comprehensive Lifestyle Modification, this is a
      combination of diet, exercise, and stress management, have improved coronary atherosclerosis.
      However, no studies have yet investigated the effects of Comprehensive Lifestyle Modification
      in patients with metabolic syndrome and/or in combination with fasting therapy.

      This study is supported by a grant from the Corona-Foundation, Germany.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>3 months</time_frame>
    <description>24-hour ambulatory blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HOMA Index</measure>
    <time_frame>3 months</time_frame>
    <description>Homeostatic Model Assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>24-hour ambulatory blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Pulse wave velocity (PWV) is a measure of arterial stiffness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROCAM</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>PROCAM risk score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCORE</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>SCORE risk score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose level</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood insulin level</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1C</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Longterm parameter for plasma glucose concentration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood creatinine level</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication use</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HADS</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Hospital Anxiety and Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POMS</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Profile of Mood States</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPSS</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Cohen Perceived Stress Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SWE</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>General self-efficacy (Skala zur Allgemeinen Selbstwirksamkeitserwartung)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Health-related quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAAS</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Mindfulness Attention Awareness Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCS</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Self-Compassion Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lifestyle questionnaire</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Questionnaire on physical activity, stress management, diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hair steroid analysis</measure>
    <time_frame>6 months, 12 months</time_frame>
    <description>Assessment of long-term glucocorticoid levels in scalp hair.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioelectrical impedance analysis</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Method for estimating body composition (body fat).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist/hip ratio</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunophenotyping</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Assessment of membrane protein expression in PBMCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal microbiota</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Characterization of gut microbiota.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolomics</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Assessment of small-molecule metabolite profiles from capillary blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene expression profiling</measure>
    <time_frame>1 week, 3 months</time_frame>
    <description>Assessment of gene expression profiles from PBMCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin- 6</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uric acid</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin-like growth factor (IGF-1)</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
    <description>Adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Framingham-Score</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>JBS3-Score</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Hypertension</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Comprehensive Lifestyle Modification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DASH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comprehensive Lifestyle Modification</intervention_name>
    <description>Vegeterian diet
Fasting (1st week)
Meditation
Yoga
Aerobic exercise</description>
    <arm_group_label>Comprehensive Lifestyle Modification</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DASH</intervention_name>
    <description>DASH diet (dietary approaches to stop hypertension)
Aerobic exercise
Progressive muscle relaxation</description>
    <arm_group_label>DASH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypertension or antihypertensive medication or subclinical atherosclerosis

          -  Metabolic syndrome

          -  Basic mobility

        Exclusion Criteria:

          -  Diabetes type 1

          -  Insulin bolus therapy

          -  Coronary artery disease

          -  Myocardial infarct, pulmonary embolism, or stroke within the past 3 months

          -  Heart failure

          -  Peripheral vascular disease

          -  Chronic kidney disease

          -  Eating disorder

          -  Dementia

          -  Other severe internal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Immanuel Hospital Berlin, Department of Internal and Complementary Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen</name>
      <address>
        <city>Essen</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2014</study_first_submitted>
  <study_first_submitted_qc>March 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2014</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universit채t Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Gustav Dobos</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

